Loading...
Évaluation des risques générée par un processus de réglementation (RA)
  |  
last updated: 09 juil. 2026
Informations générales
Risk assessment of the PROTEQFLU Vaccine - Technical Opinion No. 5486/2017.
EN
08 juin 2017
Détails de l’évaluation des risques
  • Proteqflu - equine influenza vaccine
    | Merial | Production de composés médicaux ou pharmaceutiques (humains ou animaux) (Vaccins), Use as vaccine
ProteqFlu is a vaccine intended to protect domestic horses against equine influenza (H3N8).
EN
Méthode et points à examiner
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
EN
Safety studies were conducted on non-target species involving canaries, ducks, chickens, pigs, rats and guinea pigs and the results support the product's safety profile.
EN
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
EN
It is not potentially causing significant environmental degradation or harmful to human health.
EN
The analysis of the experimental data presented in the present request show that the GMOs in question are harmless to other species of animals, to man and to the environment.
EN
The ProteqFlu vaccine is not potentially risk-causing.
EN
The ProteqFlu vaccine, CTNBio concluded that the present request complies with the pertinent norms and legislation that aim to guarantee the biosafety of the environment, agriculture, human and animal health.
EN
Molecular traditional methods. 
EN
Partage d’informations avec d’autres bases de données
Oui
Non
Non
Information supplémentaire
FR
Les fichiers qui font référence à ce document Montré dans la recherche
Type de fichier Champs Fichier(s) :
Décision de pays ou tout autre communication Évaluation des risques 1